This video provides an in depth technical demonstration of the “PARC data stewardship wizard (DSW)”, the tool PARC projects should use to document their project specific data management plans. An additional video is available explaining PARC Data Management Plans /DSW at more generic level (“Parc Data Management/Plan Data Stewardship Wizard Instruction Video”).

This video provides an overview why PARC in general and PARC projects in particular should implement data management plans (DMP). Further, the advantages of using reference FAIR implementation Profiles, the selection of Data Stewardship Wizard as DMP tool for PARC and important aspects towards getting started with DSW are explained. An additional video is available demonstrating the PARC data stewardship wizard in more detail (“PARC_Data Stewardship Wizard walkthrough”).

This training material supports effective data management in PARC projects, focusing on the development and continuous updating of Data Management Plans (DMPs). It addresses ethical and regulatory requirements, data protection, and collaborative workflows to ensure data quality, long-term value, and reuse in line with FAIR principles.

Training session on harmonised QA/QC implementation in the PARC project, focusing on consistent approaches to sampling, validation, reporting, and data comparability across diverse chemical monitoring studies.

This presentation explores the production and use of certified reference materials for human biomonitoring, highlighting practical aspects of method validation, sample stability, and traceability in support of EU chemical risk assessment efforts.

Focuses on showcasing FAIR data collections through the use of dashboards, highlighting how persistent identifiers (PIDs), well-structured metadata, and institutional data presentation can enhance transparency, accessibility, and reuse.

Presents the use of salivary leukocytes as a non-invasive biomatrix for assessing DNA damage and repair in biomonitoring studies using the comet assay, including methodological optimization and validation of both fresh and cryopreserved samples.

Introduces the principles and applications of Non-Targeted Screening (NTS) using LC-HRMS, with emphasis on broader chemical characterisation, harmonised workflows, and methodological developments in the field.

Covers SSbD policy context, scoping actions, and a case-based walkthrough of the PLANETS Workflow, with full supporting materials and worksheet.

This webinar explores the exposome framework in toxicology, focusing on multi-stressor interactions, long-term effects, and regulatory implications for environmental health.

Covers the role of industrial toxicology in regulatory compliance, product stewardship, and risk-based evaluation across sectors including chemicals, pharmaceuticals, and consumer goods.

An educational resource offering scientific insights and practical examples on human biomonitoring to support chemical risk assessment and public health decision-making.

This seminar discusses in vitro tools to assess toxicology of chemical mixtures.

Webinar series on exposomics, a growing field studying lifelong exposures and health.

The webinar focus on methods to evaluate combined exposures and chemical mixtures, using computer models and in vivo/in vitro testing.

Covers REACH requirements for QSAR-based adaptations, ECHA’s evaluation approach, and typical deficiencies identified in submitted QSAR studies.

Provides an overview of IUCLID dossier preparation and submission, detailing entities, dataset structure, validation, and the use of ECHA’s Cloud Services.

Focuses on addressing FAIR data challenges in research, highlighting persistent identifiers, metadata, and semantic interoperability through expert presentations and interactive discussions.

A practical guide to navigating FAIR principles, drafting Data Management Plans, and sharing research outcomes, tailored to the needs of diverse research stakeholders.

Presents the RACE tool, supporting exposure assessment for food contaminants by comparing intake estimates with health-based guidance values.

A deep dive into FAIRsFAIR’s work on metadata, semantic interoperability, and persistent identifiers, with insights into aligning technical solutions across European research infrastructures.

This presentation focuses on the concept and principles of Human Biomonitoring, specifically the classification and application of biomarkers, distinguishing between those used for exposure assessment, susceptibility evaluation, and research purposes. Highlights how the selection of specific biomarkers can provide insights into bioavailability and bioactivation over time, making them valuable tools for assessing aggregate exposure in diverse populations.

This presentation focuses on the core objectives of the HBM4EU project, providing a comprehensive overview of how each objective aligns with the project's work package structure. It highlights the strategic organisation of HBM4EU's activities and illustrates how the objectives collectively support the development of a coherent and policy-relevant human biomonitoring framework across Europe.

This presentation focuses on exhaled breath condensate (EBC) as a biological matrix for chromium biomonitoring, explaining its production, potential applications, and the procedures for sample collection. It outlines the method developed by the Health & Safety Laboratory in the UK for chromium speciation in EBC, supported by findings from a feasibility study. 

This presentation focuses on the role of human biomonitoring (HBM) in enhancing chemical risk assessment and supporting evidence-based policymaking. It highlights the need for reliable data on human exposure to chemicals across the EU, including variations over time, geography, and population sub-groups. The presentation also explores how HBM can inform policy by providing tools to interpret exposure data, assess health impacts, and monitor patterns and trends in chemical exposure across Europe.

This presentation focuses on the molecular pathways involved in the development of asbestos-related diseases, emphasising the roles of oxidative stress, DNA repair, and xenobiotic metabolism. It explores how both germline mutations and single-nucleotide polymorphisms (SNPs) within these pathways influence individual susceptibility. By understanding these mechanisms, researchers can identify clinically relevant biomarkers that support early diagnosis and risk assessment.

This presentation focuses on the fundamental terminology and principles of sampling, providing a clear overview of key concepts essential for designing and conducting human biomonitoring studies. It includes a brief introduction to the sample selection strategy developed for HBM4EU alignment studies.

This presentation provides a brief overview of key human biomonitoring (HBM) initiatives worldwide, offering insight into their scope and objectives. It includes a short introduction to the HBM4EU project, highlighting its role in coordinating efforts across Europe to advance the use of HBM in environmental health research and policymaking.

This presentation focuses on the use of blood and urine as primary biological media in HBM, outlining key characteristics of selected biomarkers in each matrix. It provides practical guidance on sample collection methods, highlighting potential pitfalls and necessary contingencies. Strategies for aliquoting and storage are discussed in detail, emphasising the importance of maintaining homogeneity in urine samples and the role of fractionation in sample pretreatment. Considerations for storage conditions, including cooling, freezing, and the use of preservatives, are also addressed to ensure sample integrity.

This presentation focuses on the basic principles of matrix and biomarker selection in human biomonitoring, guiding participants from the identification of exposure biomarkers to their application in population studies. 

Focuses on the health risks associated with asbestos exposure, emphasizing its link to a range of diseases including asbestosis, pleural conditions, and multiple forms of cancer. Highlights malignant mesothelioma as a particularly aggressive cancer of the pleura and peritoneum, primarily caused by asbestos exposure. Discusses current challenges in diagnosing mesothelioma and the ongoing investigation into potential serum biomarkers, such as Soluble Mesothelin Related Protein (SMRP), Fibulin-3, and Survivin, for improving early detection and monitoring treatment response.

Focuses on exploring the role of gene-environment interactions in disease development, using asbestosis as a case study to illustrate the combined impact of genetic and environmental factors. Highlights findings from a nested case-control study that incorporated cumulative asbestos exposure, smoking data, and PCR-based genotyping, with logistic regression used to assess risk. Emphasises the importance of investigating how genetic factors interact with lifestyle and occupational exposures to shape disease outcomes.

This SOP focuses on standardising dermal exposure assessment to total chromium through wipe sampling, based on established IOM procedures and OSHA Method ID-125G guidelines. The protocol utilises SKC Ghost wipes to collect representative samples of hand contamination, supporting consistent and reliable monitoring of metals such as chromium, zinc, nickel, and hydrocarbons across different exposure scenarios.

WHO’s Emergency Risk Communication course, outlining key concepts, core modules, and strategies to support effective communication during public health emergencies.